Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial

Table 1

Titration regimes for recruited subjects.

FBG (mmol/L)	Insulin dose
All or nocturnal hypoglycaemia	-2 U
Group 2:	According to clinical condition by the investigator; -1-2 U or no change
Group 3:
Group 1:	No change
Group 2:
Group 3:
Group 1:	+2 U
Group 2:
Group 3:
All	According to clinical condition by the investigator; +2-4 U

FBG: fasting blood glucose.